Caroline Baumal - Jan 3, 2023 Form 4 Insider Report for Apellis Pharmaceuticals, Inc. (APLS)

Role: Chief Medical Officer
Signature: /s/ David Watson, attorney-in-fact for Caroline Baumal
Stock symbol: APLS
Transactions as of: Jan 3, 2023
Transactions value $: $2,463,720
Form type: 4
Date filed: 1/5/2023, 06:57 PM
Next filing: Jan 5, 2024

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	APLS	Common Stock	Award	$0	+35.5K	+26654.42%	$0.00	35.7K	Jan 3, 2023	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	APLS	Stock Option (Right to Buy)	Award	$2.46M	+49K		$50.28	49K	Jan 3, 2023	Common Stock	49K	$50.28	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	This represents a Restricted Stock Unit award granted on 01/03/2023 that vest 25% annually over four years from grant date subject to continued service.
F2	This represents a stock option was granted on 01/03/2023 and has a four year vesting period. 25% vest one year from grant and then monthly thereafter subject to continued service.